| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Kelly David M serves as a Director at FHI and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 16 sells. Those positions are worth an estimated $843K at current prices.
Historically, Kelly David M's trades have earned a middling insider score of 59/100 across 3 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +34.3%.
The biggest single holding is MLAB (~$843K) as Director. The recent filings there lean toward selling, a net 11,461 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 6, 2018 | MLAB Mesa Laboratories Inc /co/ | Director | Sale+OE | 1,700 | $210.94 | $358,598.00 | -37.0% | |
| Sep 13, 2018 | MLAB Mesa Laboratories Inc /co/ | Director | Sale+OE | 700 | $190.01 | $133,007.00 | -19.4% | |
| Jun 12, 2017 | MLAB Mesa Laboratories Inc /co/ | Director | Sell | 1,000 | $142.00 | $142,000.00 | -17.4% |